Bibliografische notaFunding Information:
A. Murgaski reports grants from Fonds Wetenschappelijk Onderzoek (FWO) and Kom op tegen Kanker (KOTK) during the conduct of the study. E. Hadadi reports grants from Research Foundation Flanders (FWO) during the conduct of the study. S. Hoves reports a patent 20200392234 pending, a patent 20190284284 pending, a patent 20180346581 pending, a patent 20170051065 pending, a patent 20160220669 pending, a patent 9192667 issued, a patent 20150073129 pending, and a patent 20140314771 pending; and also reports employment with Roche Diagnostics GmbH and ownership of Hoffmann La Roche stock. S. Deschoemaeker reports grants from Stichting tegen Kanker post-doctoraal mandaat (2021-023) during the conduct of the study. M. Schmittnaegel reports employment with Roche Diagnostics GmbH. C.H. Ries reports personal fees from Roche during the conduct of the study; personal fees from Macomics Ltd. and Dr. Carola Ries Consulting outside the submitted work; also has a patent for EP12158519 issued. D. Laoui reports other support from Roche and grants from FWO, VUB, and Collen-Francqui Foundation during the conduct of the study. No disclosures were reported by the other authors.
assistance. They thank Pascal Merchiers, Akiko Iwasaki, and Orr-El Weizman for providing reagents. The authors thank the VIB singularity platform for support and access to scRNA-seq technologies and Ria Roelandt for the library preparations. They thank Mika€el Pittet, Patrick De Baetselier, Jo Van Ginderachter, and Kiavash Movahedi for insightful discussions. A. Murgaski, H. Van Damme, I. Vanmeerbeek, and S.M. Arnouk are supported by an FWO doctoral fellowship (1S16718N, 1S24117N, 1S06821N, and 1S78120N). S. Janssens and V. Bosteels are funded by an EOS grant (G0G7318N) and FWO predoctoral fellowship. A.D. Garg was supported by FWO (G0B4620N; EOS grant 30837538), KU Leuven, Kom op Tegen Kanker, and VLIR-UOS. G. Vande Velde was supported by KU Leuven Internal Funds (C24/17/061 and STG/15/024). D. Laoui was supported by grants from FWO (12Z1820N), Kom op Tegen Kanker, Stichting tegen kanker, and Vrije Universiteit Brussel.
© 2022 American Association for Cancer Research Inc.. All rights reserved.
Copyright 2022 Elsevier B.V., All rights reserved.